Upload
fraley
View
26
Download
0
Embed Size (px)
DESCRIPTION
Avian influenza ( Bird flu ). Introduction. Avian influenza or “ Bird Flu ” , the disease Which Was first identified in Italy more than 100 years ago . - PowerPoint PPT Presentation
Citation preview
1
Avian influenza ( Bird flu )
2
Introduction Avian influenza or “ Bird Flu ” , the disease Which
Was first identified in Italy more than 100 years ago.
Is a contagious disease of animals caused by viruses that normally infect only birds and , less commonly ,pigs . While all bird species are thought to be susceptible to infection , domestic poultry flocks are especially vulnerable to infections that can rapidly
reach epidemic proportions.
3
What is A I
•Caused by avian iflu virus which occur naturally in birds.
•Wild animals carry virus in their intestine but usually do not get sick from it.
•Very contagious among birds and can make some domestic birds (chickens, ducks and turkeys) very sick and kill them
4
Do A I VIRUSES INFECT HUMANS
•They do not usually infect humans, but more than 100 cases of human infection have occurred since 1997.
5
Types of influenza virus
•Three types: A, B, C
•Type A : Can infect people, birds, pigs, horses, whales and others
•Type B :* human virus * Not classified according to subtype
* Cause human epidemics but not pandemic.
•TYPE C: cause mild illness in humans.
6
7
How are AI viruses (H5N1) different from human flu viruses
•There are different subtypes of type A IV.•Certain protein on the surface of the virus:
( HA) hemagglutinine-- (NA) neuraminidase •There are 16 different HA and 9 different NA
subtypes•Many different combinations HA and NA are
possible , all known subtypes can be found in birds.•There are only three known A subtypes of human AI
H1N1, H1N2, H3N2.•IV are constantly changing
8
H5N1The most subtype which make concern:
* Mutates rapidly.
* has a documented propensity to acquire genes from virus infecting other animals.
* Have high pathogenicity and can cause
severe disease in humans.
* Infected birds excrete virus for at least
10 days orally and in faeces, facilitating
further spread at live poultry markets
and by migratory birds .
9
Congestion ,cyanosis of comb
10
Hgs in the pericardium
11
•Preservation measures such as freezing and refrigeration will not reduce the concentration or kill the virus, so frozen poultry should be handled with the same precautions.
Cont
•Eggs may contain virus both on the outside (shell) and inside (white and yolk), eggs should be properly cooked (no runny yolks).
12
DiagnosisIndividuals infected With H5 N1 are considered to be infectious starting from one day prior to the onset of symptoms up to seven days after the onset of symptoms.
The cases of the human influenza A
)H5N1 (Can be classified into:
13
Possible case : which is a person with acute lower respiratory tract illness of ale nupt onset of :fever> 38 , sore throat , cough , dyspnea +one or more of :- Contact within prior 7 days with a confirmed case of influenza A ( H5N1)- Recent ( within prior 7 days) visit to a poultry farm known to have out breaks or endemic for HPAI - Recent (within prior 7 days) contact with birds that were unwell or that have died of an illness.-Having worked in a laboratory (within prior 7 days) that is processing samples from persons or animals that are
suspected of HPAI infection.
14
*Probable case: It is a possible case and
Limited laboratory evidence for influenza A ( H5N1) Such as IFA test +ve Using H2 monoclonal
antibodies(
15
Confirmed case: An individual for whom laboratory testing demonstrates
One or more of the following:
A) Positive Viral culture for influenza A ( H5N1) .
OR B) Positive PCR for influenza A( H5N1) .
OR c) Immunofluorescence antibody ( IFA) test positive using influenza A /H5 monoclonal antibodies.
OR D) A four – fold rise in H5 specific Ab titre.
16
WHO teams in Vietnam and Thailand are conducting studies to detect the earliest stage of human transmission , and a new virus adopted for efficient human to human transmission Would spread very rapidly due to the emerge
of a completely new virus.
To date , this has never occurred.
17
Vaccine against H5N1In human
Currently available vaccines will not protect against disease caused by the H5N1strain in
humans.
-An available vaccine prototype virus , developed using
the 2003 strain of H5N1 ( which caused the two human cases in Hong Kong ) cannot be used now because the laboratory analysis indicates that the
virus has mutated significantly.
18
Annual vaccines are produced for routine use in protecting humans during seasonal epidemics of influenza , they offer no protection against infection with the H5N1
avian virus.
The experience in the production of influenza vaccines is also considerable . However , at least four months would be needed to produce a new vaccine , in significant quantities , capable of conferring protection against a new
virus subtype.
19
Drugs used in prevention and treatment
There are two classes of drugs available Now
1 )M2 inhibitors: - Amantadine (Adamine) .
- Rimantadine
2) Neuraminidase inhibitors: - Oseltamivir ( Tami flu )
- Zanimivir
20
ADAMINE =Amantadine Hydrochloride 100 mg Capsule
oral capsules for treatment and prophylaxis of Respiratory tract against influenza A virus
-it is not a replacement of influenza vaccines
Treatment: *Adult 2 Capsules ( 200 mg ) / day
OR 1 capsule 2 / day
For 5-7 days
*Old age ( above 65 years )
1 Capsule ( 100 mg ) / day.
21
Prophylaxis -Not used as a prophylaxis against
influenza in children .
-treatment dose is used as a prophylaxis in:
. All the period of epidemic ( 5-6 weeks )
OR. In addition with vaccine ( 1-2 weeks )
-application of infection control rules.
22
TAMIFLU
(OSELTAMIVIR PHOSPHATE)
CAPSULES 75 mg oral use
Powder for oral use
Treatment:
TAMIFLU is indicated for the treatment of uncomplicated acute illness due to influenza infection in patients 1 year and older who have been symptomatic for no
more than 2 days.
23
Prophylaxis of influenza: TAMIFLU is indicated for the prophylaxis of influenza in adult patients and adolescents 13 years and
older. Is not a substitute for early vaccination
24